BRTX [NASD]
BioRestorative Therapies, Inc.
Index- P/E- EPS (ttm)-20.01 Insider Own17.80% Shs Outstand3.52M Perf Week-0.59%
Market Cap10.70M Forward P/E- EPS next Y-2.42 Insider Trans100.48% Shs Float2.88M Perf Month-23.76%
Income-33.50M PEG- EPS next Q-0.49 Inst Own20.00% Short Float1.79% Perf Quarter-34.62%
Sales0.05M P/S232.67 EPS this Y-30.60% Inst Trans25.96% Short Ratio2.09 Perf Half Y-17.40%
Book/sh5.72 P/B0.60 EPS next Y-13.10% ROA-276.40% Target Price37.00 Perf Year-85.26%
Cash/sh6.17 P/C0.55 EPS next 5Y- ROE-405.20% 52W Range2.75 - 32.00 Perf YTD-21.21%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-89.12% Beta-
Dividend %- Quick Ratio40.30 Sales past 5Y- Gross Margin- 52W Low26.55% ATR0.36
Employees7 Current Ratio40.30 Sales Q/Q-70.60% Oper. Margin- RSI (14)45.17 Volatility11.67% 9.62%
OptionableNo Debt/Eq0.00 EPS Q/Q93.60% Profit Margin- Rel Volume0.43 Prev Close3.42
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume24.72K Price3.48
Recom2.00 SMA20-8.23% SMA50-11.48% SMA200-44.05% Volume10,045 Change1.77%
Jun-30-22 07:30AM  
Jun-22-22 07:30AM  
07:00AM  
Jun-13-22 07:00AM  
Apr-29-22 08:00AM  
Apr-18-22 08:00AM  
Apr-04-22 08:00AM  
Mar-10-22 08:00AM  
Feb-16-22 08:30AM  
Feb-07-22 09:00AM  
07:45AM  
Feb-02-22 08:00AM  
Jan-26-22 06:00AM  
Jan-11-22 06:00AM  
Jan-06-22 06:00AM  
Jan-04-22 06:00AM  
Dec-22-21 07:28AM  
05:53AM  
Dec-21-21 04:01PM  
06:00AM  
Dec-20-21 06:00AM  
Dec-02-21 06:00AM  
Nov-23-21 04:05PM  
Nov-22-21 12:00PM  
Nov-19-21 12:27PM  
06:00AM  
Nov-10-21 06:00AM  
Nov-09-21 02:20PM  
Nov-04-21 09:21PM  
Oct-26-21 04:05PM  
08:00AM  
Sep-23-21 09:00AM  
Sep-02-21 09:00AM  
Aug-31-21 09:00AM  
Aug-19-21 06:00AM  
Aug-11-21 08:30AM  
Aug-09-21 11:58AM  
Jun-07-21 07:00AM  
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ALSTODT LANCEPresident, CEO, COBJun 30Buy3.101,1003,408182,021Jul 01 09:20 AM
Broadrick Dale10% OwnerJun 21Buy3.68100368295,473Jun 23 03:42 PM
Broadrick Dale10% OwnerJun 17Buy3.806002,282295,373Jun 23 03:42 PM
Broadrick Dale10% OwnerJun 16Buy3.812,0007,611294,773Jun 17 05:05 PM
ALSTODT LANCEPresident, CEO, COBJun 16Buy3.736002,238180,921Jun 17 04:02 PM
Kristal Robert EugeneChief Financial OfficerJun 15Buy3.611947007,994Jun 15 05:50 PM
ALSTODT LANCEPresident, CEO, COBJun 15Buy3.687002,578180,321Jun 15 05:30 PM
Broadrick Dale10% OwnerJun 15Buy3.721,2004,464292,773Jun 17 05:05 PM
ALSTODT LANCEPresident, CEO, COBJun 14Buy3.915001,956179,621Jun 15 11:01 AM
ALSTODT LANCEPresident, CEO, COBJun 13Buy3.95200790179,121Jun 14 11:55 AM
Broadrick Dale10% OwnerJun 13Buy3.921,3005,097291,573Jun 15 04:45 PM
Broadrick Dale10% OwnerJun 10Buy4.236002,540290,273Jun 13 03:33 PM
Broadrick Dale10% OwnerJun 09Buy4.271,0004,266289,673Jun 13 03:33 PM
ALSTODT LANCEPresident, CEO, COBJun 08Buy4.28100428178,921Jun 09 11:41 AM
Broadrick Dale10% OwnerJun 08Buy4.332,40010,395288,673Jun 09 04:42 PM
Kristal Robert EugeneChief Financial OfficerJun 07Buy4.562009127,800Jun 07 12:22 PM
Broadrick Dale10% OwnerJun 07Buy4.723,60017,003286,273Jun 09 04:42 PM
Broadrick Dale10% OwnerJun 06Buy4.933,00014,798282,673Jun 07 01:52 PM
Broadrick Dale10% OwnerJun 03Buy4.901,2005,879279,673Jun 07 01:52 PM
Broadrick Dale10% OwnerJun 02Buy4.691,0004,688278,473Jun 06 01:35 PM
Broadrick Dale10% OwnerJun 01Buy4.469,21341,122277,473Jun 03 04:03 PM
ALSTODT LANCEPresident, CEO, COBJun 01Buy4.60200920178,821Jun 03 06:58 AM
Broadrick Dale10% OwnerMay 27Buy3.6110,95739,592268,260Jun 01 04:30 PM
ALSTODT LANCEPresident, CEO, COBMay 26Buy3.522,7009,494178,621May 27 10:23 AM
Broadrick Dale10% OwnerMay 26Buy3.514,95017,364259,303May 31 05:18 PM
Broadrick Dale10% OwnerMay 26Sale3.442,0006,876257,303May 31 05:18 PM
ALSTODT LANCEPresident, CEO, COBMay 02Buy3.954001,579175,921May 02 05:14 PM
Kristal Robert EugeneChief Financial OfficerApr 08Buy5.717,60043,3967,600Apr 11 10:47 AM
Broadrick Dale10% OwnerApr 06Buy5.662,50014,150254,353Apr 08 04:23 PM
Broadrick Dale10% OwnerApr 05Buy5.7146,000262,640251,853Apr 07 04:15 PM
Broadrick Dale10% OwnerMar 31Buy4.7210,70050,488316,972Apr 01 04:54 PM
Broadrick Dale10% OwnerMar 29Buy5.125,00025,600306,272Apr 01 04:54 PM
Broadrick Dale10% OwnerMar 21Buy4.3510,00043,500205,853Mar 29 04:52 PM
Broadrick Dale10% OwnerMar 09Buy4.0011,87547,500195,853Mar 29 04:52 PM
Broadrick Dale10% OwnerMar 08Buy4.008,12532,500183,978Mar 29 04:52 PM
Broadrick Dale10% OwnerMar 07Buy4.4324,392108,057175,853Mar 29 04:52 PM
Broadrick Dale10% OwnerMar 04Buy5.513,80020,938301,272Mar 29 04:52 PM
Broadrick Dale10% OwnerMar 03Buy5.4747,648260,635297,472Mar 29 04:52 PM
Broadrick Dale10% OwnerMar 02Buy5.6147,840268,382249,824Mar 29 04:52 PM
Broadrick Dale10% OwnerMar 01Buy5.552,27012,598201,984Mar 29 04:52 PM
ALSTODT LANCEPresident, CEO, COBJan 24Buy3.401,4704,998163,083Jan 24 05:03 PM
ALSTODT LANCEPresident, CEO, COBJan 05Buy3.852,0007,700161,613Jan 05 04:52 PM
ALSTODT LANCEPresident, CEO, COBDec 01Buy5.507994,394159,613Dec 02 10:00 AM
ALSTODT LANCEPresident, CEO, COBNov 23Buy6.002,50015,000158,814Nov 23 05:15 PM
ALSTODT LANCEPresident, CEO, COBNov 22Buy6.313962,499156,314Nov 22 05:29 PM
Silva FranciscoVP of Research and DevelopmentNov 19Buy6.664,00026,62611,829Nov 22 12:17 PM
ALSTODT LANCEPresident, CEO, COBNov 16Buy6.714,50030,201155,918Nov 16 06:07 PM
Silva FranciscoVP of Research and DevelopmentNov 16Buy6.737,82652,6327,829Nov 16 05:23 PM